Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2953 (LINC02953) is an annotated long intergenic non-coding RNA (lincRNA) gene in the human genome. lincRNAs are characterized as autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap protein-coding genes. They belong to the broader family of long non-coding RNAs (lncRNAs), which are known to regulate gene expression through various mechanisms, such as chromatin remodeling, transcriptional regulation, and potentially enhancer-like activity. While some lincRNAs have well-established biological and disease functions, the specific physiological role and clinical significance of LINC02953 remain unclear in the current literature, with no known associations to drugs, biomarkers, or direct disease mechanisms. It is not regarded as a canonical therapeutic target such as a receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2953 (LINC02953).